Press release
Investigation announced for Investors who lost money with shares of Outlook Therapeutics, Inc. (NASDAQ: OTLK)
An investigation for investors in Outlook Therapeutics, Inc. (NASDAQ: OTLK) shares over potential securities laws violations.
Investors who purchased shares of Outlook Therapeutics, Inc. (NASDAQ: OTLK), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Outlook Therapeutics, Inc. (NASDAQ: OTLK regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Cranbury, NJ based Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, a proprietary ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age related macular degeneration and other retina diseases.
On August 30, 2023, Outlook Therapeutics, Inc. issued a press release "announc[ing] the U.S. Food and Drug Administration (FDA) has issued a CRL to the Company's BLA for ONS-5010, an investigational ophthalmic formulation of bevacizumab under development to treat wet AMD. While the FDA acknowledged the NORSE TWO pivotal trial met its safety and efficacy endpoints, the Agency concluded it could not approve the BLA during this review cycle due to several CMC issues, open observations from pre-approval manufacturing inspections, and a lack of substantial evidence."
Shares of Outlook Therapeutics, Inc. (NASDAQ: OTLK) declined to $0.21 per share on August 31, 2023.
Those who purchased shares of Outlook Therapeutics, Inc. (NASDAQ: OTLK) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors who lost money with shares of Outlook Therapeutics, Inc. (NASDAQ: OTLK) here
News-ID: 3197318 • Views: …
More Releases from Shareholders Foundation
Investigation announced for Long-Term Investors in shares of WEBTOON Entertainme …
An investigation on behalf of current long-term investors in shares of WEBTOON Entertainment Inc. (NASDAQ: WBTN) concerning potential breaches of fiduciary duties by certain directors of WEBTOON Entertainment Inc. was announced.
Investors who are current long term investors in WEBTOON Entertainment Inc. (NASDAQ: WBTN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long…
Deadline on Nov. 19th coming up in Lawsuit for Investors who lost money with Dom …
A deadline is coming up on November 19, 2024 in the lawsuit filed for certain investors of Domino's Pizza, Inc. (NYSE: DPZ) over alleged securities laws violations by Domino's Pizza, Inc.
Investors who purchased shares of Domino's Pizza, Inc. (NYSE: DPZ) have certain options and there are strict and short deadlines running. Deadline: November 19, 2024. NYSE: DPZ stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
Lawsuit filed for Investors who lost money with shares of United Parcel Service, …
An investor, who purchased shares of United Parcel Service, Inc. (NYSE: UPS), filed a lawsuit over alleged violations of Federal Securities Laws by United Parcel Service, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of United Parcel Service, Inc. (NYSE: UPS) have certain options and for certain investors are short and strict deadlines running. Deadline: December 9, 2024. NYSE: UPS investors should contact the Shareholders…
Long-Term Investors in shares of Palo Alto Networks, Inc. (NASDAQ: PANW) should …
An investigation was announced for current long-term investors in shares of Palo Alto Networks, Inc. (NASDAQ: PANW) concerning potential breaches of fiduciary duties by certain directors of Palo Alto Networks, Inc.
Investors who are current long term investors in Palo Alto Networks, Inc. (NASDAQ: PANW) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current…
More Releases for Therapeutics
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
Pruritus Drug Market – Key Players are Cara Therapeutics, Enteris BioPharma, N …
The Pruritus Drug Market research report is a significant investigation of changing business sector elements, driving elements, impediments, and limitations that have been considered the most extensive impacts on market development. Adroit investigative devices, for example, Porter’s Five Forces examination, SWOT examination, and Feasibility examination study have likewise been utilized by the report to offer an exhaustive information of the market. It will go about as a key research report…
Dravet Syndrome Therapeutics- Pipeline Analysis 2018 | Zogenix, Inc., Ovid Thera …
Dravet syndrome is a form of severe myoclonic epilepsy that occurs in infants during their first year of age. If left untreated, it can be associated with other types of seizures, and status epilepticus. Children having Dravet syndrome are generally observed with poor cognitive skills and hyperactivity.
Download the sample report @ https://www.pharmaproff.com/request-sample/1098
It severely affects the person’s quality of life and around 10-20% of the patient are estimated to die due…
Global mRNA Cancer Vaccines and Therapeutics Market to 2025| Moderna Therapeutic …
Researchmoz added Most up-to-date research on "Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2019-2025" to its huge collection of research reports.
mRNA Cancer Vaccines and Therapeutics Market report includes (6 Year Forecast 2019-2025) includes Overview, classification, industry value, price, cost and gross profit. It also offers in-intensity insight of the mRNA Cancer Vaccines and Therapeutics industry masking all vital parameters along with, Drivers, Market Trends, Market Dynamics,…
Global Pruritus Therapeutics Market Report 2019 Companies included Actavis, Trev …
Market Reports Company has recently published 7th edition of Pruritus Therapeutics Market Report which covers historic data of year 2013 to 2018 along with a forecast till year 2026.
For inquiry or free sample pages email us at: sales@marketreportscompany.com
The report provides a comprehensive view on the current state and future prospects of the market which analyzes different strategies for business growth. The global Pruritus Therapeutics market was valued at USD xx…
MRNA Vaccines & Therapeutics Market 2019 Global Analysis By Key Players – Mode …
WiseGuyReports.Com Publish a New Market Research Report On –“ MRNA Vaccines & Therapeutics Market 2019 Global Analysis By Key Players – Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics”.
Description:-
The mRNA Vaccines & Therapeutics industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, mRNA Vaccines & Therapeutics market size to maintain the average annual growth rate of XXX from…
